MYC and diffuse large B-cell lymphoma: We recently reported that OxPhos‐ and MYC‐associated gene signatures are highly correlated in DLBCL (Donati et al, 2022) and that overexpressed MYC sensitizes cells to inhibition of OxPhos activity, either indirectly with tigecycline (D'Andrea et al, 2016) or directly with IACS‐010759 (Donati et al, 2022).